These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38640170)

  • 1. Parkinson's Disease Risk Variant rs9638616 is Non-Specifically Associated with Altered Brain Structure and Function.
    Welton T; Teo TWJ; Chan LL; Tan EK; Tan LCS
    J Parkinsons Dis; 2024; 14(4):713-724. PubMed ID: 38640170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered functional connectivity in the default mode network is associated with cognitive impairment and brain anatomical changes in Parkinson's disease.
    Lucas-Jiménez O; Ojeda N; Peña J; Díez-Cirarda M; Cabrera-Zubizarreta A; Gómez-Esteban JC; Gómez-Beldarrain MÁ; Ibarretxe-Bilbao N
    Parkinsonism Relat Disord; 2016 Dec; 33():58-64. PubMed ID: 27659747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of white matter characteristics with tract-based spatial statistics according to diffusion tensor imaging in early Parkinson's disease.
    Li XR; Ren YD; Cao B; Huang XL
    Neurosci Lett; 2018 May; 675():127-132. PubMed ID: 29199095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans: A Genome-Wide Association Study.
    Foo JN; Chew EGY; Chung SJ; Peng R; Blauwendraat C; Nalls MA; Mok KY; Satake W; Toda T; Chao Y; Tan LCS; Tandiono M; Lian MM; Ng EY; Prakash KM; Au WL; Meah WY; Mok SQ; Annuar AA; Chan AYY; Chen L; Chen Y; Jeon BS; Jiang L; Lim JL; Lin JJ; Liu C; Mao C; Mok V; Pei Z; Shang HF; Shi CH; Song K; Tan AH; Wu YR; Xu YM; Xu R; Yan Y; Yang J; Zhang B; Koh WP; Lim SY; Khor CC; Liu J; Tan EK
    JAMA Neurol; 2020 Jun; 77(6):746-754. PubMed ID: 32310270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI-derived brain iron, grey matter volume, and risk of dementia and Parkinson's disease: Observational and genetic analysis in the UK Biobank cohort.
    Casanova F; Tian Q; Williamson DS; Qian Y; Zweibaum D; Ding J; Atkins JL; Melzer D; Ferrucci L; Pilling LC
    Neurobiol Dis; 2024 Jul; 197():106539. PubMed ID: 38789058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson's disease.
    Inguanzo A; Sala-Llonch R; Segura B; Erostarbe H; Abos A; Campabadal A; Uribe C; Baggio HC; Compta Y; Marti MJ; Valldeoriola F; Bargallo N; Junque C
    Parkinsonism Relat Disord; 2021 Jan; 82():16-23. PubMed ID: 33227683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson's Disease.
    Surova Y; Lampinen B; Nilsson M; Lätt J; Hall S; Widner H; ; van Westen D; Hansson O
    PLoS One; 2016; 11(6):e0157755. PubMed ID: 27362763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural and dopaminergic correlates of fatigue in Parkinson's disease.
    Kang SY; Bang M; Hong JY; Oh J; Kim JS; Han YM; Chang SK; Lee SA; Yoon U; Shin NY
    J Neural Transm (Vienna); 2020 Mar; 127(3):301-309. PubMed ID: 31894419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased prevalence of vertebrobasilar dolichoectasia in Parkinson's disease and its effect on white matter microstructure and network.
    Li S; Zhu Y; Lai H; Da X; Liao T; Liu X; Deng F; Chen L
    Neuroreport; 2024 Jul; 35(10):627-637. PubMed ID: 38813904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain MRI morphometric analysis in Parkinson's disease patients with sleep disturbances.
    Radziunas A; Deltuva VP; Tamasauskas A; Gleizniene R; Pranckeviciene A; Petrikonis K; Bunevicius A
    BMC Neurol; 2018 Jun; 18(1):88. PubMed ID: 29925331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?
    Duncan GW; Firbank MJ; Yarnall AJ; Khoo TK; Brooks DJ; Barker RA; Burn DJ; O'Brien JT
    Mov Disord; 2016 Jan; 31(1):103-10. PubMed ID: 26202802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistically Defined Parkinson's Disease Executive and Memory Cognitive Phenotypes: Demographic, Behavioral, and Structural Neuroimaging Comparisons.
    Crowley SJ; Banan G; Amin M; Tanner JJ; Hizel L; Nguyen P; Brumback B; Rodriguez K; McFarland N; Bowers D; Ding M; Mareci TA; Price CC
    J Parkinsons Dis; 2021; 11(1):283-297. PubMed ID: 33216042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication of a Novel Parkinson's Locus in a European Ancestry Population.
    Grover S; Kumar-Sreelatha AA; Bobbili DR; May P; Domenighetti C; Sugier PE; Schulte C; ; Elbaz A; Krüger R; Gasser T; Sharma M;
    Mov Disord; 2021 Jul; 36(7):1689-1695. PubMed ID: 33760272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential White Matter Regional Alterations in Motor Subtypes of Early Drug-Naive Parkinson's Disease Patients.
    Wen MC; Heng HSE; Lu Z; Xu Z; Chan LL; Tan EK; Tan LCS
    Neurorehabil Neural Repair; 2018 Feb; 32(2):129-141. PubMed ID: 29347868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White matter alterations in Parkinson's disease with normal cognition precede grey matter atrophy.
    Rektor I; Svátková A; Vojtíšek L; Zikmundová I; Vaníček J; Király A; Szabó N
    PLoS One; 2018; 13(1):e0187939. PubMed ID: 29304183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical gray and subcortical white matter associations in Parkinson's disease.
    Sterling NW; Du G; Lewis MM; Swavely S; Kong L; Styner M; Huang X
    Neurobiol Aging; 2017 Jan; 49():100-108. PubMed ID: 27776262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of diffusion kurtosis changes in Parkinson's disease subtypes.
    Sejnoha Minsterova A; Klobusiakova P; Pies A; Galaz Z; Mekyska J; Novakova L; Nemcova Elfmarkova N; Rektorova I
    Parkinsonism Relat Disord; 2020 Dec; 81():96-102. PubMed ID: 33120076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural MRI in Idiopathic Parkinson's Disease.
    De Micco R; Russo A; Tessitore A
    Int Rev Neurobiol; 2018; 141():405-438. PubMed ID: 30314605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gray and White Matter Contributions to Cognitive Frontostriatal Deficits in Non-Demented Parkinson's Disease.
    Price CC; Tanner J; Nguyen PT; Schwab NA; Mitchell S; Slonena E; Brumback B; Okun MS; Mareci TH; Bowers D
    PLoS One; 2016; 11(1):e0147332. PubMed ID: 26784744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain structural correlates of depressive symptoms in Parkinson's disease patients at different disease stage.
    Li Y; Huang P; Guo T; Guan X; Gao T; Sheng W; Zhou C; Wu J; Song Z; Xuan M; Gu Q; Xu X; Yang Y; Zhang M
    Psychiatry Res Neuroimaging; 2020 Feb; 296():111029. PubMed ID: 31918166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.